| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/2009 | EP1313482B1 Pharmaceutical composition and method for treating hypogonadism |
| 04/29/2009 | EP1304992B1 Topical gel delivery systems for treating skin disorders |
| 04/29/2009 | EP1296652B1 Topical pharmaceutical formulations and methods of treatment |
| 04/29/2009 | EP1105413B1 Hepatitis c inhibitor tri-peptides |
| 04/29/2009 | EP1066286B1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 04/29/2009 | EP1047433A4 Cellulose derivatives and colorectal cancer risk reduction |
| 04/29/2009 | EP1043327B1 Phosphonocephem derivatives, process for the preparation of the same, and use thereof |
| 04/29/2009 | CN101421290A 17-phosphorous steroid derivatives useful as progesterone receptor modulators |
| 04/29/2009 | CN101421288A Novel amphiphilic derivatives of alpha-C-phenyl-N-tert-butylnitrone |
| 04/29/2009 | CN101421282A Treatment of hyperproliferative diseases with vinca alkaloidn-oxide and analogs |
| 04/29/2009 | CN101421281A Substituted imidazo[2,1-b]thiazole compounds and their use for producing drugs |
| 04/29/2009 | CN101421280A Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 04/29/2009 | CN101421279A Imidazo compounds |
| 04/29/2009 | CN101421278A Condensed imidazole derivatives as aldosterone synthase inhibitors |
| 04/29/2009 | CN101421276A Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof |
| 04/29/2009 | CN101421273A Spiro-imidazo compounds |
| 04/29/2009 | CN101421272A 3-unsubstituted N-(aryl- or heteroarvl)-pyrazolori (1,5-a) pyrimidines as kinase inhibitors |
| 04/29/2009 | CN101421271A Purine derivatives as adenosine receptor activator |
| 04/29/2009 | CN101421269A Inhibitors of tyrosine kinases and uses thereof |
| 04/29/2009 | CN101421268A Pyrazoloquinolones as potent PARP inhibitors |
| 04/29/2009 | CN101421265A Thiazole compounds as protein kinase b (pkb) inhibitors |
| 04/29/2009 | CN101421264A Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 04/29/2009 | CN101421263A Novel crystalline compounds |
| 04/29/2009 | CN101421262A Compounds and compositions as protein kinase inhibitors |
| 04/29/2009 | CN101421261A Tetracyclic steroid derivatives useful as progesterone receptor modulators |
| 04/29/2009 | CN101421260A Chromen-2-one derivatives |
| 04/29/2009 | CN101421256A Thiadiazolidinone inhibitors of ptpase |
| 04/29/2009 | CN101421255A Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 04/29/2009 | CN101421253A Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/29/2009 | CN101421252A 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin D2 receptor antagonists |
| 04/29/2009 | CN101421251A 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments |
| 04/29/2009 | CN101421249A 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments |
| 04/29/2009 | CN101421248A 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments |
| 04/29/2009 | CN101421247A Novel imidazole derivatives, preparation and user thereof as medicine |
| 04/29/2009 | CN101421246A Layout of power semiconductor contacts on a cooling surface |
| 04/29/2009 | CN101421244A Process for the preparation of caprolactam CGRP antagonist intermediate |
| 04/29/2009 | CN101421243A Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/29/2009 | CN101421242A Dicarboxamide derivatives |
| 04/29/2009 | CN101421240A Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof |
| 04/29/2009 | CN101421239A Bicyclic tetrahydropyrrole compounds |
| 04/29/2009 | CN101421237A Metabotropic glutamate receptor-potentiating soindolones |
| 04/29/2009 | CN101421235A 5-amido-2-carboxamide indoles |
| 04/29/2009 | CN101421231A Salt of aliskiren with sulfuric acid |
| 04/29/2009 | CN101421229A Improved crystalline material |
| 04/29/2009 | CN101421035A Improved preparation of molecular imprinted polymers |
| 04/29/2009 | CN101420989A Polymer no donor predrug nanofiber coating for medical devices and therapy |
| 04/29/2009 | CN101420982A Dry direct compression fast disintegrating tablet |
| 04/29/2009 | CN101420981A Combinations for the treatment of proliferative diseases |
| 04/29/2009 | CN101420979A Method of treatment of myocardial infarction |
| 04/29/2009 | CN101420970A Implantable sensors and implantable pumps and anti-scarring agents |
| 04/29/2009 | CN101420963A Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
| 04/29/2009 | CN101420962A Modified macromolecule |
| 04/29/2009 | CN101420961A Reduction of the titratable acidity and the prevention of tooth and other bone degeneration |
| 04/29/2009 | CN101420960A Method for treating aortic stenosis with non-antibacterial tetracycline formulations |
| 04/29/2009 | CN101420959A Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine A2A receptor agonists |
| 04/29/2009 | CN101420958A Co-administration of adenosine A1 receptor antagonists and anticonvulsants |
| 04/29/2009 | CN101420957A Therapeutic agent for inflammatory bowel disease |
| 04/29/2009 | CN101420956A Fluoroquinolone carboxylic acid salt compositions |
| 04/29/2009 | CN101420955A Dihydrodiazepines useful as inhibitors of protein kinases |
| 04/29/2009 | CN101420954A The use of deferiprone and methods to treat and/or prevent friedreich ataxia resulting from intracellular mishandling of iron |
| 04/29/2009 | CN101420953A Mazindol combination in the treatment of attention deficit/hyperactivity |
| 04/29/2009 | CN101420952A Treatment of duchenne muscular dystrophy |
| 04/29/2009 | CN101420951A Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom |
| 04/29/2009 | CN101420950A Treatment of Duchenne muscular dystrophy |
| 04/29/2009 | CN101420949A Use of biarylcarboxamides in the treatment of hedgehog pathway-related disorders |
| 04/29/2009 | CN101420948A Intramuscular antiviral treatments |
| 04/29/2009 | CN101420947A Alpha-2-delta ligands for non-restorative sleep |
| 04/29/2009 | CN101420946A Tamsulosin-containing percutaneous absorption type preparation |
| 04/29/2009 | CN101420945A Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis |
| 04/29/2009 | CN101420944A Novel pharmaceutical compositions for optimizing substitution treatments and extending the pharmacopoeia to global treatment of addictions |
| 04/29/2009 | CN101420943A Chewing composition containing coenzyme Q10 |
| 04/29/2009 | CN101420942A Small-molecule modulators of TRP-P8 activity |
| 04/29/2009 | CN101420941A Use of gpr119 receptor agonists for increasing bone mass and for treating osteoporosis, and combination therapy relating thereto |
| 04/29/2009 | CN101420939A Asymmetric membranes for drug delivery devices |
| 04/29/2009 | CN101420938A Low flush niacin formulation |
| 04/29/2009 | CN101420936A Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive |
| 04/29/2009 | CN101420935A Sterilization of corticosteroids with reduced mass loss |
| 04/29/2009 | CN101420933A Paediatric amino acid solution for parenteral nutrition |
| 04/29/2009 | CN101420931A Solid preparation for oral application |
| 04/29/2009 | CN101420867A Novel nutraceutical compositions |
| 04/29/2009 | CN101420854A Boron-containing small molecules as anti-inflammatory agents |
| 04/29/2009 | CN101418334A Diterpenes diterpenoids natural product inhibitor for main protease of coronaviruses such as SARS and screen method thereof |
| 04/29/2009 | CN101418325A Inonotus obliquus extracellular and incellular mixed exopolysaccharide and preparation method thereof and pharmaceutical use |
| 04/29/2009 | CN101418294A Antisense nucleic acid of methicillin-resistant staphylococcus aureus resistance gene mecA |
| 04/29/2009 | CN101418293A Tiny RNA-21 antisense oligonucleotides and use thereof |
| 04/29/2009 | CN101418016A Phosphorylation cephalosporin derivates |
| 04/29/2009 | CN101418015A Ceftriaxone phosphorylation derivates |
| 04/29/2009 | CN101418001A Dipeptidase-IV inhibitor sulfonyl urea derivates |
| 04/29/2009 | CN101418000A DPP-IV inhibitor derivates containing benzofuran sulfonyl ureas |
| 04/29/2009 | CN101417999A Piperazines derivates, preparation method thereof and application thereof in medicine |
| 04/29/2009 | CN101417997A Inhibitor compounds containing benzo2-aminoimidazloe skeleton and preparation method thereof |
| 04/29/2009 | CN101417995A Phenoxy pyrimidine derivates and preparation method and use thereof |
| 04/29/2009 | CN101417988A Biguanide piperazines dipeptidyl peptidase IV inhibitor |
| 04/29/2009 | CN101417987A DPP-IV inhibitor with sulfonamide formyl piperazine structure |
| 04/29/2009 | CN101417974A Antitumor compound Cu(C10H12NO2)2 |
| 04/29/2009 | CN101417971A Indolines compounds, preparation method and pharmaceutical application thereof |
| 04/29/2009 | CN101417969A Cinnamoyl pyrrolidine derivates and preparation method and use thereof |
| 04/29/2009 | CN101417967A Histone deacetylase inhibitor, compounds thereof and use thereof |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN101417949A Eicosatetraenoic acid derivates and preparation method and use thereof |